Volume 57, Issue 6, Pages (June 2010)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Early Detection of Prostate Cancer in 2007
Volume 194, Issue 2, Pages (August 2015)
Volume 184, Issue 4, Pages (October 2010)
Volume 178, Issue 3, Pages (September 2007)
The PSA Era is not Over for Prostate Cancer
Volume 71, Issue 6, Pages (June 2017)
Volume 64, Issue 6, Pages (December 2013)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Catarina Dinis Fernandes, Cuong V. Dinh, Marcel J. Steggerda, Leon C
Testosterone Therapy in Men With Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)
Volume 62, Issue 5, Pages (November 2012)
Volume 67, Issue 1, Pages (January 2015)
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
Volume 60, Issue 1, Pages (July 2011)
Volume 67, Issue 4, Pages (April 2015)
Volume 67, Issue 3, Pages (March 2015)
Volume 53, Issue 5, Pages (May 2008)
Volume 58, Issue 1, Pages (July 2010)
Nerve Distribution along the Prostatic Capsule
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 58, Issue 1, Pages (July 2010)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Angelo J. Cambio, Christopher P. Evans  European Urology 
Volume 59, Issue 6, Pages (June 2011)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
European Urology Oncology
Volume 53, Issue 4, Pages (April 2008)
Intraductal Carcinoma of the Prostate: Anonymous to Ominous
Prostate Cancer Detection: A View of the Future
Elmar Heinrich, Frank Schiefelbein, Georg Schoen  European Urology 
Volume 59, Issue 4, Pages (April 2011)
Volume 69, Issue 6, Pages (June 2016)
Volume 52, Issue 3, Pages (September 2007)
Photoselective Vaporesection of the Prostate with a Front-firing Lithium Triborate Laser: Surgical Technique and Experience After 215 Procedures  Yong-Guang.
Volume 70, Issue 5, Pages (November 2016)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 71, Issue 1, Pages (January 2017)
Volume 68, Issue 6, Pages (December 2015)
Leonard S. Marks, Jiaoti Huang  European Urology 
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 65, Issue 1, Pages (January 2014)
Volume 50, Issue 5, Pages (November 2006)
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 65, Issue 3, Pages (March 2014)
European Urology is “Your” Journal
Volume 49, Issue 6, Pages (June 2006)
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Volume 53, Issue 6, Pages (June 2008)
Catarina Dinis Fernandes, Cuong V. Dinh, Marcel J. Steggerda, Leon C
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 5, Pages (May 2007)
Salvage Local Treatments After Focal Therapy for Prostate Cancer
Presentation transcript:

Volume 57, Issue 6, Pages 1111-1114 (June 2010) Focal Laser Ablation for Prostate Cancer Followed by Radical Prostatectomy: Validation of Focal Therapy and Imaging Accuracy  Uri Lindner, Nathan Lawrentschuk, Robert A. Weersink, Sean R.H. Davidson, Orit Raz, Eugen Hlasny, Deanna L. Langer, Mark R. Gertner, Theodorus Van der Kwast, Masoom A. Haider, John Trachtenberg  European Urology  Volume 57, Issue 6, Pages 1111-1114 (June 2010) DOI: 10.1016/j.eururo.2010.03.008 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Fixed 3-mm-thick prostate slices before paraffin embedding. White arrow points toward laser fiber placement; red arrows indicate grossly visible ablated area. European Urology 2010 57, 1111-1114DOI: (10.1016/j.eururo.2010.03.008) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 2 Vital staining of the prostate for cytokeratin 8. (A) Whole-mount vital stain of the prostate. Arrows indicate position of the laser fibers. (B) Zoom in view using ScanScope XT slide scanning systems. No vital cells are evident between the laser fibers. European Urology 2010 57, 1111-1114DOI: (10.1016/j.eururo.2010.03.008) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 3 Ablation extending to the prostatic capsule. (A) Ablation zone extends all the way to the posterior border. Arrows mark where the laser fibers were positioned. No viable cells were seen inside the 18-mm ablated area. (B) Ablation zone extending posteriorly and laterally. Arrows mark the position of the laser fibers. European Urology 2010 57, 1111-1114DOI: (10.1016/j.eururo.2010.03.008) Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 4 Registration of ablation in magnetic resonance (MR) imaging and pathology. (A) MR image with the damage contouring. Black arrows indicate where the laser fibers were placed. (B) Same pathologic slice. Black arrows indicate where the laser fibers were placed. Red arrows indicate where the fiducial markers were placed. European Urology 2010 57, 1111-1114DOI: (10.1016/j.eururo.2010.03.008) Copyright © 2010 European Association of Urology Terms and Conditions